Similar articles

• Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).

  Huestis MA, Henningfield JE, Cone EJ. Huestis MA, et al. J Anal Toxicol. 1992 Sep-Oct;16(5):283-90. doi: 10.1093/jat/16.5.283. J Anal Toxicol. 1992. PMID: 1338216
• Screening for cannabinoids in blood using EMIT: concentrations of delta-9-tetrahydrocannabinol in relation to EMIT results.

  Gjerde H. Gjerde H. Forensic Sci Int. 1991 Jul-Aug;50(1):121-4. doi: 10.1016/0379-0738(91)90140-e. Forensic Sci Int. 1991. PMID: 1657743
• Concerning blood cannabinoids and the effect of residual THCCOOH on calculated exposure time.

  Bogusz M. Bogusz M. J Anal Toxicol. 1993 Sep;17(5):313-6. doi: 10.1093/jat/17.5.313. J Anal Toxicol. 1993. PMID: 8107469 No abstract available.
• Marijuana and alcohol use among 1023 trauma patients. A prospective study.

  Soderstrom CA, Trifillis AL, Shankar BS, Clark WE, Cowley RA. Soderstrom CA, et al. Arch Surg. 1988 Jun;123(6):733-7. doi: 10.1001/archsurg.1988.01400300079013. Arch Surg. 1988. PMID: 2835941 Review.
• Marijuana metabolism in the context of urine testing for cannabinoid metabolite.

  Morgan JP. Morgan JP. J Psychoactive Drugs. 1988 Jan-Mar;20(1):107-15. doi: 10.1080/02791072.1988.10524379. J Psychoactive Drugs. 1988. PMID: 2839654 Review. No abstract available.